All Topics

Subscribe
Article
Algorithmic Pricing Under Fire: State Restrictions on Personalized and Surveillance Pricing
State regulation of algorithmic pricing is rapidly evolving, with California, Connecticut, Maryland, and New Jersey enacting new restrictions while New York considers even stricter measures. The key distinction lies in whether pricing algorithms use competitor data to address antitrust concerns or consumer-specific personal data to address fairness and deception issues. With several provisions already in effect and others phasing in through 2027, businesses must navigate varying rules by industry, product t
United States Consumer
GT
Greenberg Traurig, LLP
Article
September 2026 Visa Bulletin: EB-5 Unreserved Visa Numbers Remain Unavailable for India
The September 2026 Visa Bulletin reveals critical changes for EB-5 investors, particularly those from India, as unreserved visa numbers become unavailable for the remainder of FY2026. While set-aside categories remain current across all countries, the bulletin warns of potential further retrogression and highlights the importance of understanding how country of chargeability and investment category selection impact visa availability and processing timelines.
United States Immigration
GT
Greenberg Traurig, LLP
Article
BIOSECURE Act Update: Court Enjoins WuXi AppTec’s 1260H Designation, but Strategic and Compliance Clocks Keep Running
The U.S. District Court for the District of Columbia has preliminarily enjoined the Department of War from enforcing WuXi AppTec's Section 1260H designation, finding the agency misread its evidence on state and military affiliation. However, this ruling does not close alternative pathways to biotechnology company of concern (BCC) designation under the BIOSECURE Act, and earlier supply-chain restrictions continue to drive near-term compliance decisions with a critical June 30, 2027 deadline for sub-tier supp
United States Government
GT
Greenberg Traurig, LLP
Article
The Emerging Federal Overlay On Healthcare Transactions, Amid Expanding State Review Regimes
Federal and state healthcare transparency requirements are rapidly evolving, creating new compliance obligations for private equity sponsors and strategic acquirers in healthcare transactions. As CMS expands ownership disclosure rules and states implement transaction review regimes, deal teams must navigate an increasingly complex regulatory landscape that affects diligence, timing, and closing processes.
United States Finance
D
Dechert
See more